REQUEST A DEMO
Total
USD $0.00
Search more companies

Borden Company (Private) Limited (Singapore)

Main Activities: Biological Product (except Diagnostic) Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Borden Company (Private) Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: manufacture of other biological products and preparations for human use (manuf medicinal & pharmaceutical prods); Secondary Business Activity: wholesale of medicinal and pharmaceutical products (western)

Headquarters
9 Jalan Kilang, #06-01 Borden Centre, Singapore
Singapore; Singapore; Postal Code: 159409

Contact Details: Purchase the Borden Company (Private) Limited report to view the information.

Basic Information
Total Employees:
Purchase the Borden Company (Private) Limited report to view the information.
Outstanding Shares:
Purchase the Borden Company (Private) Limited report to view the information.
Financial Auditors:
Purchase the Borden Company (Private) Limited report to view the information.
Incorporation Date:
March 26, 1960
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Borden Company (Private) Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
99.46%
Total operating revenue
99.46%
Net Profit (Loss) for the Period
96.41%
Total assets
89.53%
Total equity
76.87%
Net Profit Margin
-0.77%
Return on Equity (ROE)
8.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?